THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

PROBLEM TO BE SOLVED: To create a new therapeutic agent by concretely elucidating the possibility of N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2-phenylethenesulfonamide or its salt for therapy of diseases. SOLUTION: An airway inflammation inhibitor, a ventilation dysfunction...

Full description

Saved in:
Bibliographic Details
Main Authors HIRANO YASUNO, KOAKUTSU AKIKO, FUJIMORI AKIRA, YUYAMA KOBO, SANAGI MASANAO
Format Patent
LanguageEnglish
Published 04.11.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To create a new therapeutic agent by concretely elucidating the possibility of N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2-phenylethenesulfonamide or its salt for therapy of diseases. SOLUTION: An airway inflammation inhibitor, a ventilation dysfunction ameliorating agent, a therapeutic agent of hypoxemia and/or a progression inhibitor of chronic respiratory insufficiency of patients suffering from chronic obstructive pulmonary diseases comprise the N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]-2-phenylethenesulfonamide or its pharmaceutically acceptable salt as an active ingredient. COPYRIGHT: (C)2005,JPO&NCIPI
Bibliography:Application Number: JP20030099103